CBD and Hemp Extracts: How Do We Move Forward?

Location: Lower Level, North Convention Center

Wednesday, November 7 | 1:30-4:30pm

Over the last five years, demand for cannabidiol (CBD) and related whole-plant hemp extracts has grown exponentially. Colorado-based Hemp Business Journal estimates the total CBD industry—including both hemp and marijuana-derived sources—grew to $360 million in U.S. sales in 2017, reflecting a 37 percent growth rate. Despite the surging demand for hemp-derived products, the CBD industry continues to face myriad challenges. In this three-hour workshop, leading hemp executives and attorneys will review the current landscape for CBD and strategies to mature as an industry and overcome hurdles to growth.

Industry experts will discuss and debate:

  • Raising capital and transacting business with financial institutions
  • Evolution of product formulations and how to reach new distribution channels
  • Implications of Hemp Industry Association’s lawsuit against DEA over its marijuana extract rule;
  • Regulatory considerations including the Hemp Farming Act of 2018, GW Pharma, state initiatives and DSHEA


  • Tim Gordon, Functional Remedies
  • Todd Harrison, Venable LLC
  • Bob Hoban, Hoban Law Group
  • Jim Prochnow, Greenberg Traurig
  • Ashish Talati, Amin Talati Upadhye
  • Stuart Tomc, CV Sciences Inc


Underwritten By:

CFH, Ltd

CV Sciences

Elixinol, LLC


Neptune Wellness Solutions

Rad Extracts